Firefly Neuroscience Inc. (AIFF) Stock: Surges 35% After NeuroSigma ADHD Therapy Partnership

TLDR Firefly Neuroscience AIFF stock surged 35% after NeuroSigma partnership announcement. Partnership expands Monarch ADHD therapy access through Firefly clinician network. Monarch eTNS System offers FDA-cleared non-drug ADHD treatment for children. Firefly Evoke platform analyzes brain activity using EEG and ERP technology. Collaboration targets improved personalized ADHD care through advanced solutions. Firefly Neuroscience Inc. (AIFF) [...]

The post Firefly Neuroscience Inc. (AIFF) Stock: Surges 35% After NeuroSigma ADHD Therapy Partnership appeared first on Blockonomi.